11-(Chloromethyl)-12-formyl-13-oxo-1,8-diazatricyclo[7.4.0.0,2,7]trideca-2,4,6,9,11-pentaene-10-carbonitrile

Catalog No. :
ACMLFS146
CAS No. :
571155-05-0
Molecular Formula :
C14H8ClN3O2
Molecular Weight :
285.69

IUPAC Name:3-(chloromethyl)-2-formyl-1-oxo-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile

11-(Chloromethyl)-12-formyl-13-oxo-1,8-diazatricyclo[7.4.0.0,2,7]trideca-2,4,6,9,11-pentaene-10-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$114.00Login to see priceInquiryInquiry
100mg95%$159.00Login to see priceInquiryInquiry
250mg95%$220.00Login to see priceInquiryInquiry
1g95%$537.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name11-(Chloromethyl)-12-formyl-13-oxo-1,8-diazatricyclo[7.4.0.0,2,7]trideca-2,4,6,9,11-pentaene-10-carbonitrile
IUPAC Name3-(chloromethyl)-2-formyl-1-oxo-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile
MDL No.MFCD03985205
Molecular FormulaC14H8ClN3O2
Molecular Weight285.69
SMILESN#CC(C(CCl)=C1C=O)=C2NC3=CC=CC=C3N2C1=O
InChI KeyDWZDEZBSNZVZCJ-UHFFFAOYSA-N
SynonymPyrido[1,2-a]benzimidazole-4-carbonitrile, 3-(chloromethyl)-2-formyl-1,5-dihydro-1-oxo-;11-(Chloromethyl)-12-formyl-13-oxo-1,8-diazatricyclo[7.4.0.0,2,7]trideca-2,4,6,9,11-pentaene-10-carbonitrile
CAS No.571155-05-0

Synthetic Route by SureRoute

1. ACMLFS146 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMLFS146 route product structure diagram
    ACMLFS146571155-05-0
Inquiry

2. ACMLFS146 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMLFS146 route product structure diagram
    ACMLFS146571155-05-0
Inquiry

Comments (0)